Author
Listed:
- Nacho Aguilo
(Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III)
- Jesus Gonzalo-Asensio
(Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III)
- Samuel Alvarez-Arguedas
(Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III)
- Dessislava Marinova
(Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III)
- Ana Belen Gomez
(Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III)
- Santiago Uranga
(Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III)
- Ralf Spallek
(LIONEX GmbH)
- Mahavir Singh
(LIONEX GmbH)
- Regine Audran
(Centre Hospitalier Universitaire Vaudois (CHUV))
- François Spertini
(Centre Hospitalier Universitaire Vaudois (CHUV))
- Carlos Martin
(Grupo de Genética de Micobacterias, Dpto. Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III
Servicio de Microbiología, Hospital Universitario Miguel Servet, ISS Aragón)
Abstract
MTBVAC is a live-attenuated Mycobacterium tuberculosis vaccine, currently under clinical development, that contains the major antigens ESAT6 and CFP10. These antigens are absent from the current tuberculosis vaccine, BCG. Here we compare the protection induced by BCG and MTBVAC in several mouse strains that naturally express different MHC haplotypes differentially recognizing ESAT6 and CFP10. MTBVAC induces improved protection in C3H mice, the only of the three tested strains reactive to both ESAT6 and CFP10. Deletion of both antigens in MTBVAC reduces its efficacy to BCG levels, supporting a link between greater efficacy and CFP10- and ESAT6-specific reactogenicity. In addition, MTBVAC (but not BCG) triggers a specific response in human vaccinees against ESAT6 and CFP10. Our results warrant further exploration of this response as potential biomarker of protection in MTBVAC clinical trials.
Suggested Citation
Nacho Aguilo & Jesus Gonzalo-Asensio & Samuel Alvarez-Arguedas & Dessislava Marinova & Ana Belen Gomez & Santiago Uranga & Ralf Spallek & Mahavir Singh & Regine Audran & François Spertini & Carlos Mar, 2017.
"Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis,"
Nature Communications, Nature, vol. 8(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms16085
DOI: 10.1038/ncomms16085
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Elena Campos-Pardos & Santiago Uranga & Ana Picó & Ana Belén Gómez & Jesús Gonzalo-Asensio, 2024.
"Dependency on host vitamin B12 has shaped Mycobacterium tuberculosis Complex evolution,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
- Joshua S. Woodworth & Helena Strand Clemmensen & Hannah Battey & Karin Dijkman & Thomas Lindenstrøm & Raquel Salvador Laureano & Randy Taplitz & Jeffrey Morgan & Claus Aagaard & Ida Rosenkrands & Ceci, 2021.
"A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin,"
Nature Communications, Nature, vol. 12(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms16085. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.